ARTICLE | Clinical News
Oregovomab: Interim Ph IIb QPT-ORE-002 data
February 10, 2017 8:43 PM UTC
Quest’s OncoQuest Inc. subsidiary reported interim data from the open-label, U.S. and Italian Phase IIb QPT-ORE-002 trial in 97 patients with newly diagnosed, advanced epithelial ovarian, adnexal or p...
BCIQ Company Profiles
BCIQ Target Profiles